275 results found

After almost three years of the Unified Patent Court (the UPC), the Unitary Patent (UP) Guidelines are being further refined, with the new amendments coming into force as of 1 April 2026.

As of today (27 June 2024) the Milan section of the central division of the Unified Patent Court (UPC) has officially opened its doors.

The Düsseldorf Local Division of the Unified Patent Court has adopted The Hague's four-step equivalence test in a patent dispute between Wonderland Nurserygoods and Cybex.

The NHS is now offering an injectable form of Keytruda (pembrolizumab) that can be administered in under two minutes, dramatically reducing treatment times from over an hour. This advancement, following last year's introduction of injectable nivolumab, promises to save hundreds of thousands of hours annually while cutting costs and improving patient care across cancer treatment services.

Under UK law, there is no standalone "image right" or statutory personality right, unlike other jurisdictions. Instead, celebrities must rely on a patchwork of protections, including passing off and trade mark infringement.

This brought some clarity following the confusion caused by the UK leaving the EU which necessitated a redistribution of the cases originally earmarked for the London Central Division.

The Court of First Instance of the UPC, in decisions dated 4 and 31 July 2024, ordered the revocation within the relevant states of two European patents owned by Dexcom, Inc. relating to continuous glucose monitoring, EP3435866 and EP3797685.

Last year we reported that the EPO signed a validation agreement with Lao People's Democratic Republic (PDR). The EPO have now announced that this agreement will come into force on 1 April 2025.

The CJEU clarified that SPCs cannot be granted for new therapeutic uses if prior authorizations exist for the same active ingredients, narrowing the interpretation of "first marketing authorisation" under Article 3(d).

The Enlarged Board of Appeal of the European Patent Office issued the decision in referral G2/21 on 23 March 2023. This referral concerned the admissibility of post-published evidence...

The EPO annually update their guidelines which provide comprehensive information on all aspects of the search, examination, granting and post-granting processes at the EPO.

Today, 1 September 2024, Romania joins the Unitary Patent system. This is the first territorial extension of the Unitary Patent since it began in 2023. The addition of Romania increases the number of

The latest chapter in the long-running dispute between Swatch Group and Samsung is attracting attention not because of the finding of trade mark infringement itself, but because of the scale of the damages now...

In the recent decision of the Brussels Local Division of the UPC (UPC_CFI_582/2024), the Court emphasized that if an applicant delays requesting provisional...

The Republic of Moldova has officially joined the European Patent Organisation as its 40th member state, fundamentally changing the patent validation process for applicants. This development eliminates the additional validation fee previously required and automatically includes Moldova in European Patent applications filed after 1 June 2026. With over 400 UK-owned European Patents already validated in Moldova, the accession raises questions about how this streamlined process will impact future patent protec

Boult can announce that we have been once again ranked in the gold band by the WTR 1000 for 2023, their highest grade available.

The Preparatory team for the Unified Patent Court (UPC) has just issued an ‘implementation roadmap' outlining the key activities and milestones of the UPC in the coming months ahead...

The recent explosion in Artificial Intelligence (AI) technology has led to advances in many key areas of technology. From manufacture to medicine, and many other areas in between...